Florian Kron
Impact in
-
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Antifungal resistance and susceptibility 5
- Clostridium difficile and Clostridium perfringens research 2
-
- Lung Cancer Treatments and Mutations 6
- Co-authors
- Anna Kron (18 shared papers)Michael Hallek (10 shared papers)Oliver A. Cornely (12 shared papers)Kai Hübel (3 shared papers)Michael P. Lux (1 shared paper)Mohamad Mohty (2 shared papers)Thomas Zander (5 shared papers)Richard Noppeney (2 shared papers)
- Journals
- European Journal Of Haematology (4 papers)Mycoses (4 papers)Journal of Clinical Oncology (3 papers)Infection (3 papers)Bone Marrow Transplantation (2 papers)
- Partner nations
- GermanyUnited StatesSpain
In The Last Decade
Florian Kron
35 papers receiving 194 citations
Peers
Comparison fields: 5 of 51
- Applied Microbiology and Biotechnology 5
- Hematology 28
- Infectious Diseases 42
- Oncology 56
- Pathology and Forensic Medicine 22
Countries citing papers authored by Florian Kron
This map shows the geographic impact of Florian Kron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Florian Kron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Florian Kron more than expected).
Fields of papers citing papers by Florian Kron
This network shows the impact of papers produced by Florian Kron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Florian Kron. The network helps show where Florian Kron may publish in the future.
Co-authors
The 25 scholars most cited alongside Florian Kron, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 45 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 25 | |
| 2 | 2020 | 19 | |
| 3 | 2019 | 18 | |
| 4 | 2023 | 14 | |
| 5 | 2019 | 13 | |
| 6 | 2021 | 9 | |
| 7 | 2018 | 9 | |
| 8 | 2018 | 8 | |
| 9 | 2014 | 7 | |
| 10 | 2021 | 7 | |
| 11 | 2017 | 7 | |
| 12 | 2020 | 6 | |
| 13 | 2021 | 6 | |
| 14 | 2018 | 6 | |
| 15 | 2016 | 5 | |
| 16 | 2018 | 4 | |
| 17 | 2022 | 4 | |
| 18 | 2022 | 4 | |
| 19 | 2023 | 3 | |
| 20 | 2023 | 3 |
About Florian Kron
Florian Kron is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 45 papers that have together received 200 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (6 papers), Cancer Genomics and Diagnostics (5 papers), Antifungal resistance and susceptibility (5 papers), CAR-T cell therapy research (4 papers), Biosimilars and Bioanalytical Methods (4 papers), Lymphoma Diagnosis and Treatment (3 papers), Blood transfusion and management (2 papers) and Clostridium difficile and Clostridium perfringens research (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (5 citations), Hematology (28 citations), Infectious Diseases (42 citations), Oncology (56 citations) and Pathology and Forensic Medicine (22 citations). Florian Kron has collaborated with scholars based in Germany, United States and Spain. Frequent co-authors include Anna Kron, Michael Hallek, Oliver A. Cornely, Kai Hübel, Michael P. Lux, Mohamad Mohty, Thomas Zander, Richard Noppeney, Bertram Glaß and Helmut Ostermann. Their work appears in journals such as European Journal Of Haematology, Mycoses, Journal of Clinical Oncology, Infection and Bone Marrow Transplantation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.